You might be right Jonzobot. Though I would argue for full results Q4'19 (i.e. AHA 2019) instead of Q1 2020. First cardio/diabetes/renal conference in 2020 is ACC in March 2020. I sure hope full results in less than a year!!!! Amarin's blueprint is looking like a good template for Resverlogix.....perhaps substitue 2019 for Amarin's 2018 REDUCE-IT milestones below. If BETonMACE is at 220+ as of mid-February, this is pretty close to the 90% mark.
January 2018: Reached 90% mark for reported and documented events
April 2018:Reached target event #
June 2018: Last patient study visitÂ
Sept 2018: Top-line results
Nov 2018: Full results presented and published
